Envista (NYSE:NVST) Announces Quarterly Earnings Results

Envista (NYSE:NVST) posted its earnings results on Wednesday. The company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.01, Zacks reports. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. Envista updated its FY 2025 guidance to 0.950-1.050 EPS.

Envista Trading Up 6.7 %

NYSE:NVST traded up $1.38 during trading hours on Thursday, hitting $21.95. The company had a trading volume of 366,005 shares, compared to its average volume of 1,991,667. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. The company has a 50-day moving average of $19.97 and a 200 day moving average of $19.10. The company has a market cap of $3.78 billion, a P/E ratio of -2.80, a P/E/G ratio of 1.82 and a beta of 1.34. Envista has a 1 year low of $15.15 and a 1 year high of $24.79.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on NVST shares. Jefferies Financial Group increased their target price on shares of Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Piper Sandler increased their target price on Envista from $17.00 to $18.00 and gave the company a “neutral” rating in a research report on Monday. Mizuho began coverage on Envista in a research report on Wednesday, December 4th. They set an “underperform” rating and a $20.00 target price for the company. Stifel Nicolaus increased their target price on Envista from $18.00 to $21.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Finally, Morgan Stanley increased their target price on Envista from $19.00 to $20.00 and gave the company an “equal weight” rating in a research report on Thursday. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $20.13.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.